Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Root

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
Nature Methods|April 9, 2024
Three million images and morphological profiles of cells treated with matched chemical and genetic perturbationsSrinivas Niranj Chandrasekaran, Beth A Cimini, Amy Goodale, et al.
Science (New York, N.Y.)|September 5, 2009
Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responsesIdo Amit, Manuel Garber, Nicolas Chevrier, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Cell|November 15, 2011
Systematic discovery of TLR signaling components delineates viral-sensing circuitsNicolas Chevrier, Philipp Mertins, Maxim N Artyomov, et al.
Nature Biotechnology|January 29, 2021
Noncanonical open reading frames encode functional proteins essential for cancer cell survivalJohn R Prensner, Oana M Enache, Victor Luria, et al.
Genome Biology|December 1, 2024
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumorsDaniel J Merk, Foteini Tsiami, Sophie Hirsch, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Cancer Discovery|February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative NeoplasmsChristian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
Nature Methods|April 9, 2024
Three million images and morphological profiles of cells treated with matched chemical and genetic perturbationsSrinivas Niranj Chandrasekaran, Beth A Cimini, Amy Goodale, et al.
Science (New York, N.Y.)|September 5, 2009
Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responsesIdo Amit, Manuel Garber, Nicolas Chevrier, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Cell|November 15, 2011
Systematic discovery of TLR signaling components delineates viral-sensing circuitsNicolas Chevrier, Philipp Mertins, Maxim N Artyomov, et al.
Nature Biotechnology|January 29, 2021
Noncanonical open reading frames encode functional proteins essential for cancer cell survivalJohn R Prensner, Oana M Enache, Victor Luria, et al.
Genome Biology|December 1, 2024
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumorsDaniel J Merk, Foteini Tsiami, Sophie Hirsch, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Cancer Discovery|February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative NeoplasmsChristian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
Pageof 20